Scientific Program – GYNECOLOGYFriday, November 13 & Saturday, November 14, 2026 |
 |
Friday, November 13
| 08:30-10:00 | SURGERY IN ENDOMETRIOSIS AND ADENOMYOSIS | HALL C |
| Capsule | ||
| Chairpersons | ||
| 08:30-08:50 |
Endometriosis and infertility: When to operate and how? |
|
| 08:50-08:55 | Discussion | |
| 08:55-09:25
08:55 |
Debate: Adenomyosis should be operated on before pregnancy Yes: |
|
| 09:15-09:35 |
Decoding the mechanisms of endometriosis-related infertility |
|
| 09:35-09:40 | Discussion | |
| 09:40-09:55 |
Adenomyosis and IVF outcomes |
|
| 09:55-10:00 | Discussion | |
| 10:00-10:30 | Coffee break, visit the exhibition and e-poster viewing |
| ALL ABOUT BACK TO PRESCRIBING HRT After 20 years, the WHO has removed the black box warning from HRT. The following sessions will address this topic. |
| 10:30-12:00 | OPTIMISING LONG TERM MENOPAUSE HEALTH | HALL C |
| Capsule | ||
| Chairpersons | Rossella Nappi, Italy | |
| 10:30-10:45 | Menopause and work ability – gaps and solutions Terhi Piltonen, Finland |
|
| 10:45-10:50 | Discussion | |
| 10:50-11:05 | Optimizing quality of life after gynecological cancer Alessandra Graziottin, Italy |
|
| 11:05-11:10 | Discussion | |
| 11:10-11:40
11:10 |
Debate: Should HRT be prescribed in asymptomatic natural menopause? For: Mark Brincat, Malta |
|
| 11:40-11:55 |
TBA |
|
| 12:00-12:05 | Short break |
| 12:05-12:30 | PLENARY SESSION | HALL A Streamed to all halls |
| Capsule | ||
| Chairpersons | ||
| 12:05-12:30 |
PCOS in OBGYN (overview of PCO in reproductive life, menopause, pregnancy etc) |
|
| 12:35-13:35 |
Industry supported session – Hall A |
| 13:35-14:30 | Lunch break, visit the exhibition and e-poster viewing |
| 14:30-15:30 | MENOPAUSE SYMPTOMS – GENESIS, IMPLICATIONS AND MANAGEMENT | HALL C |
| Capsule | ||
| Chairpersons | Alessandra Graziottin, Italy | |
| 14:30-14:45 |
Genetic determinism of menopause: SIG genetics at IMS |
|
| 14:45-14:50 | Discussion | |
| 14:50-15:05 |
VMS, peripheral or central nervous system? |
|
| 15:05-15:10 | Discussion | |
| 15:10-15:25 |
Practical management strategies of VMS/VVA |
|
| 15:25-15:30 | Discussion | |
| 15:30-15:35 | Short break |
| 15:35-17:00 | HORMONE DEPENDENT DISORDERS IN PRE AND PERI MENOPAUSAL WOMEN | HALL C |
| Capsule | ||
| Chairpersons | ||
| 15:35-15:45 |
Managing severe premenstrual disorders especially in perimenopause |
|
| 15:45-15:50 | Discussion | |
| 15:50-16:10 |
PCOS – long-term cardiometabolic implications |
|
| 16:10-16:15 | Discussion | |
| 16:15-16:25 |
Recurrent pregnancy loss in Polycystic Ovary Syndrome: Underlying genetic and metabolic contributors |
|
| 16:25-16:30 | Discussion | |
| 16:30-17:00
16:30 |
Debate: Should HRT be started in pre/peri menopausal women? For: Nick Panay, UK |
|
| 17:00-17:15 | Coffee break, visit the exhibition and e-poster viewing |
| 17:15-18:35 | POI AND EARLY MENOPAUSE | HALL C |
| Capsule | ||
| Chairpersons |
Nick Panay, UK |
|
| 17:20-17:35 |
Premature ovarian aging: Genetic causes, fertility prognosis, and health consequences |
|
| 17:35-17:50 |
Ovarian function ceases way before other organs start to fail; lessons learned from DNA testing? |
|
| 17:50-18:05 |
Is early menopause a different entity from POI? |
|
| 18:05-18:35
18:05 |
Debate: Routine use of PRP & stem cells in POI? For: |
|
Saturday, November 14
| 08:30-10:00 | NOVEL HORMONAL AND NON-HORMONAL APPROACHES IN MENOPAUSE | HALL C |
| Capsule | ||
| Chairpersons |
Johannes Ott, Austria |
|
| 08:30-08:45 |
Estetrol: Role in MHT/HRT? |
|
| 08:45-08:50 | Discussion | |
| 08:50-09:05 |
Testosterone vs DHEA – which is the best option for androgen replacement? |
|
| 09:05-09:10 | Discussion | |
| 09:10-09:25 |
Neurokinin targeted therapies – genuine alternatives to MHT? |
|
| 09:25-09:30 | Discussion | |
| 09:30-10:00
09:30 |
Debate: Should all women in menopause be offered androgens? For: Andrea Genazzani, Italy |
|
| 10:00-10:30 | Coffee break, visit the exhibition and e-poster viewing |
| 10:30-12:00 | UTERINE TRANSPLANTATION AND ARTIFICIAL OVARY | HALL C |
| Capsule | ||
| Chairpersons | ||
| 10:30-10:50 |
Robotic-assisted gynecologic procedures: Evidence, outcomes and clinical applications |
|
| 10:50-10:55 | Discussion | |
| 10:55-11:15 |
Global overview of uterus transplantation and the Balkan initiative |
|
| 11:15-11:20 | Discussion | |
| 11:20-11:35 | TBA | |
| 11:35-11:40 | Discussion | |
| 11:40-11:55 |
Artificial ovary |
|
| 11:55-12:00 | Discussion | |
| 12:00-12:05 | Short break |
| 12:05-12:30 | PLENARY SESSION | HALL A Streamed to all halls |
| Capsule | ||
| Chairpersons | ||
| 12:05-12:30 |
Epigenetics and reprogramming |
|
| 12:30-13:30 | Lunch break, visit the exhibition and e-poster viewing |
| 13:30-15:00 | MENOPAUSE AND ENDOMETRIOSIS | HALL C |
| Capsule | Endometriosis, an estrogen dependent disease, develops mostly in women of reproductive age and usually regresses after menopause or ovariectomy. Postmenopausal women with endometriosis have the same chances of having menopausal symptoms, particularly hot flashes and night sweats as women without endometriosis. Treatments depend on symptom severity and medical history. However, postmenopausal estrogen use may exacerbate endometriosis. | |
| Chairpersons | ||
| 13:30-14:00
13:30 |
Debate: Hormone therapy in menopausal women with endometriosis Yes: |
|
| 14:00-14:15 |
Management of osteoporosis in women with a history of endometriosis |
|
| 14:15-14:20 | Discussion | |
| 14:20-14:35 |
Natural progesterone versus artificial progestogens |
|
| 14:35-14:40 | Discussion | |
| 14:40-14:55 |
Metabolomics as a tool for early detection of ectopic pregnancy |
|
| 15:55-15:00 | Discussion | |
| 15:00-16:30 | IMAGING IN GYNECOLOGY | HALL C |
| Capsule | ||
| Chairpersons | ||
| 15:00-15:25 |
Diagnosis of adenomyosis: Is ultrasound accurate enough to replace histology? |
|
| 15:25-15:30 | Discussion | |
| 15:30-16:00
15:30 |
Debate: Ultrasound is a better modality to stage deep endometriosis than MRI Yes: |
|
| 16:00-16:25 |
Ovarian tumors: How accurate is the prediction of histology with imaging? |
|
| 16:25-16:30 | Discussion | |
